Adam Fine co-founded Windham Venture Partners in 2006 and has spent nearly two decades focused exclusively on healthcare investing, giving him deep continuity in one sector rather than rotating across different investment strategies. His operator background at healthcare software company I-many, combined with his early experience inside Johnson & Johnson's device ecosystem working with their venture arm, gives him an insider's perspective on how large companies evaluate and acquire healthcare innovations.